Alternatives to GenSight Biologics
GenSight Biologics is a Biotechnology tool: developing innovative gene therapies to preserve or restore vision in patients with retinal diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to GenSight Biologics
- Website
Spark Therapeutics58BiotechnologyPhiladelphia, United States$82.8MA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- Website
Alnylam Pharmaceuticals19BiotechnologyCambridge, United StatesBiopharmaceutical company pioneering RNA interference (RNAi) therapeutics to treat rare and prevalent genetic diseases.
- Website
Ray Therapeutics53BiotechnologyBerkeley, USA$243.0MPioneering vision restoration therapies for severe retinal degenerations.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
KaliVir Immunotherapeutics, Inc.57BiotechnologyPittsburgh, United States$14.0MClinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
- Website
Rocket Pharmaceuticals57BiotechnologyCranbury, USA$382.9MA biotechnology company developing genetic therapies for rare disorders.
- Website
Arc Institute56BiotechnologyPalo Alto, United States$650.0MA nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.
- Website
Verve Therapeutics56BiotechnologyCambridge, USA$300.0MDeveloping gene editing therapies to lower cholesterol.
- Website SPSpliceBio54BiotechnologyCambridge, United States$100.0M
Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.
- Website
Latus Bio54BiotechnologyBoston, USA$151.0MEngineering scalable gene therapies for broader patient populations.
- Website
SonoThera53BiotechnologySan Francisco, USA$125.0MDeveloping ultrasound-mediated nonviral genetic medicines.
- Website
Immitra Bio48BiotechnologyZürich, Switzerland$2.6MScalable, one-time curative in-vivo gene editing therapies.
- Website
Laverock Therapeutics41BiotechnologyCambridge, United Kingdom$10.0MDeveloping disease-responsive advanced therapies through programmable gene control technology.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
EyePoint Pharmaceuticals36BiotechnologyWatertown, United States$435.9MOphthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.
- Website
Coefficient Bio70BiotechnologySan Francisco, United States$15.8BAI safety and research company building reliable, interpretable, and steerable AI systems.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- JUJuno Therapeutics66BiotechnologySeattle, United States$316.7M
Biotechnology company focused on developing cancer immunotherapies.
- Website
Kite Pharma66BiotechnologySanta Monica, United States$421.2MBiotechnology company developing and commercializing cell therapies for cancer treatment.
- Website
CRISPR Therapeutics64BiotechnologyZug, Switzerland$547.0MBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Showing the 20 closest matches. See the rest on the GenSight Biologics profile.